Private equity shops thought they saw a sure-fire way to make a buck: build dozens of new power plants fueled by cheap Appalachian natural gas to replace old coal-fired units.
It hasn’t quite turned out that way, at least not yet. Many of the new plants built in the last few years aren’t kicking off as much cash as the buyout firms had expected, according to bankers. There’s not enough demand to support the huge amount of additional new capacity, driving down electricity prices. And with President Donald Trump as a booster, shutdowns of coal haven’t come as quickly as anticipated while states are acting to keep nuclear plants open.
None of the new plants appear in danger of default, analysts said. But several plant owners are now using most of the extra cash they are generating to pay down debt.
Moreover, low prices and the results of a closely watched regional power-price auction scheduled for Wednesday could force many of the gas-fired plants built in the last five years to refinance their debt. At least one new U.S. plant, owned in part by an arm of private equity firm Ares Management LP, recently did so.
Top 10 Low Price Stocks To Buy Right Now: Northrim BanCorp Inc(NRIM)
Advisors' Opinion:- [By Joseph Griffin]
Northrim BanCorp (NASDAQ: NRIM) and Hometrust Bancshares (NASDAQ:HTBI) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Northrim BanCorp (NRIM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
Northrim BanCorp Inc (NASDAQ:NRIM)’s share price hit a new 52-week high and low during trading on Thursday . The stock traded as low as $40.05 and last traded at $39.85, with a volume of 561 shares trading hands. The stock had previously closed at $40.00.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Northrim BanCorp (NRIM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Low Price Stocks To Buy Right Now: Proteon Therapeutics, Inc.(PRTO)
Advisors' Opinion:- [By Max Byerly]
Proteon Therapeutics (NASDAQ: PRTO) and Neurocrine Biosciences (NASDAQ:NBIX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.
Top 10 Low Price Stocks To Buy Right Now: GlycoMimetics, Inc.(GLYC)
Advisors' Opinion:- [By Motley Fool Transcribing]
GlycoMimetics (NASDAQ:GLYC) Q2 2018 Earnings Conference CallAug. 10, 2018 8:30 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Logan Wallace]
Allianz Asset Management GmbH purchased a new stake in GlycoMimetics Inc (NASDAQ:GLYC) during the 1st quarter, Holdings Channel reports. The firm purchased 73,433 shares of the biotechnology company’s stock, valued at approximately $1,192,000.
- [By Joseph Griffin]
GlycoMimetics (NASDAQ:GLYC)‘s stock had its “buy” rating reiterated by equities research analysts at Stifel Nicolaus in a research report issued to clients and investors on Sunday. They presently have a $24.00 price target on the biotechnology company’s stock. Stifel Nicolaus’ target price would suggest a potential upside of 64.16% from the company’s previous close.
- [By Max Byerly]
BidaskClub downgraded shares of GlycoMimetics (NASDAQ:GLYC) from a sell rating to a strong sell rating in a research report sent to investors on Saturday morning.
Top 10 Low Price Stocks To Buy Right Now: NVE Corporation(NVEC)
Advisors' Opinion:- [By Motley Fool Transcribing]
NVE (NASDAQ:NVEC) Q1 2019 Earnings Conference CallJul. 18, 2018 4:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Joseph Griffin]
Kayne Anderson Rudnick Investment Management LLC increased its holdings in NVE Co. (NASDAQ:NVEC) by 1.3% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 741,605 shares of the semiconductor company’s stock after purchasing an additional 9,645 shares during the period. Kayne Anderson Rudnick Investment Management LLC owned approximately 15.32% of NVE worth $61,635,000 at the end of the most recent quarter.
- [By Stephan Byrd]
NVE Co. (NASDAQ:NVEC) shares hit a new 52-week high and low on Wednesday . The stock traded as low as $105.88 and last traded at $103.80, with a volume of 52 shares changing hands. The stock had previously closed at $104.57.
- [By Ethan Ryder]
NVE (NASDAQ:NVEC) was downgraded by ValuEngine from a “buy” rating to a “hold” rating in a research note issued to investors on Monday.
Top 10 Low Price Stocks To Buy Right Now: MiMedx Group, Inc(MDXG)
Advisors' Opinion:- [By Cory Renauer]
Shares of MiMedx Group, Inc. (NASDAQ:MDXG), a biopharmaceutical company with a hand in the tissue repair market, rose 16.6% in September, according to data from S&P Global Market Intelligence. Investors are beginning to like the business again, following the unpaid departure of key executives and a reprieve from the Nasdaq exchange.
- [By Paul Ausick]
MiMedx Group Inc. (NASDAQ: MDXG) dropped about 9.9% Tuesday to post a new 52-week low of $3.01. Shares closed at $3.34 on Monday and the stock’s 52-week high is $18.25. Volume totaled about 30% above the daily average of around 3 million. The company had no specific news.
- [By Peter Graham]
Small cap regenerative biomaterial product and bioimplant stock MiMedx Group Inc (NASDAQ: MDXG) is the thirteenth most shorted stock on the NASDAQ with short interest of 40.54% according to Highshortinterest.com. MiMedx Group is a leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing proprietary PURION® Process among other processes, to produce safe and effective allografts. MiMedx Group is the leading supplier of placental tissue, having supplied over 1,000,000 allografts to date for application in the Wound Care, Burn, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare.
- [By Paul Ausick]
MiMedX Group Inc. (NASDAQ: MDXG) dropped about 29% Thursday to post a new 52-week low of $5.80. Shares closed at $8.21 on Wednesday and the stock’s 52-week high is $18.25. The biomedical company will restate financial reports filed for more than the last five years. The company’s CFO and its controller and treasurer were both fired Wednesday.
- [By Paul Ausick]
MiMedx Group Inc. (NASDAQ: MDXG) fell more than 10% Tuesday to post a new 52-week low of $3.52. Shares closed at $3.93 on Monday. The 52-week high is $18.25. Volume of around 4.1 million was about 40% above the daily average. The company’s CEO and COO both resigned Monday morning.
Top 10 Low Price Stocks To Buy Right Now: Colliers International Group Inc. (CIGI)
Advisors' Opinion:- [By Logan Wallace]
Five Point (NASDAQ: CIGI) and Colliers International Group (NASDAQ:CIGI) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings and dividends.
- [By Joseph Griffin]
Colliers International Gr (NASDAQ: CIGI) and Getty Realty (NYSE:GTY) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.
- [By Joseph Griffin]
A number of hedge funds have recently made changes to their positions in the business. Beutel Goodman & Co Ltd. acquired a new position in Colliers International Gr during the fourth quarter valued at approximately $117,633,000. Renaissance Technologies LLC lifted its position in Colliers International Gr by 4.5% during the fourth quarter. Renaissance Technologies LLC now owns 859,200 shares of the financial services provider’s stock valued at $51,856,000 after buying an additional 36,800 shares in the last quarter. Mackenzie Financial Corp lifted its position in Colliers International Gr by 305.1% during the fourth quarter. Mackenzie Financial Corp now owns 305,329 shares of the financial services provider’s stock valued at $18,427,000 after buying an additional 229,960 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in Colliers International Gr by 31.6% during the fourth quarter. The Manufacturers Life Insurance Company now owns 261,450 shares of the financial services provider’s stock valued at $15,779,000 after buying an additional 62,834 shares in the last quarter. Finally, Deutsche Bank AG lifted its position in Colliers International Gr by 25.2% during the fourth quarter. Deutsche Bank AG now owns 234,768 shares of the financial services provider’s stock valued at $14,168,000 after buying an additional 47,253 shares in the last quarter. 72.69% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “Colliers International Gr (CIGI) Lifted to Hold at Zacks Investment Research” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://www.tickerreport.com/bankin - [By Logan Wallace]
BidaskClub lowered shares of Colliers International Gr (NASDAQ:CIGI) (TSE:CIGI) from a buy rating to a hold rating in a research report released on Wednesday morning.
- [By Max Byerly]
Colliers International Group Inc (NASDAQ:CIGI) (TSE:CIGI) shares hit a new 52-week high on Thursday . The stock traded as high as $80.95 and last traded at $80.95, with a volume of 604 shares trading hands. The stock had previously closed at $80.50.
- [By Logan Wallace]
Colliers International Group (NASDAQ: CIGI) and BBX Capital Corp Class A (NYSE:BBX) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations.
Top 10 Low Price Stocks To Buy Right Now: S&P GSCI(GD)
Advisors' Opinion:- [By Chris Dier-Scalise]
What gives? Well, all of the top six holdings in the fund—Boeing Co (NYSE: BA), United Technologies Corporation (NYSE: UTX), Lockheed Martin Corporation (NYSE: LMT), General Dynamics Corporation (NYSE: GD), Raytheon Company (NYSE: RTN), and Northrup Grumman Corporation (NYSE: NOC)—all either met or exceeded Q4 earnings estimates. Together, those six companies make up about 45 percent of the fund.
- [By Logan Wallace]
Get a free copy of the Zacks research report on General Dynamics (GD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
General Dynamics Co. (NYSE:GD) insider S. Daniel Johnson sold 77,810 shares of the stock in a transaction on Friday, September 14th. The shares were sold at an average price of $199.85, for a total value of $15,550,328.50. Following the completion of the transaction, the insider now owns 99,333 shares of the company’s stock, valued at approximately $19,851,700.05. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
- [By Joseph Griffin]
Riverhead Capital Management LLC increased its holdings in shares of General Dynamics (NYSE:GD) by 223.5% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 12,055 shares of the aerospace company’s stock after purchasing an additional 8,328 shares during the period. Riverhead Capital Management LLC’s holdings in General Dynamics were worth $2,663,000 at the end of the most recent reporting period.
Top 10 Low Price Stocks To Buy Right Now: Independence Realty Trust, Inc.(IRT)
Advisors' Opinion:- [By Max Byerly]
Get a free copy of the Zacks research report on Independence Realty Trust (IRT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
BlackRock Inc. grew its position in Independence Realty Trust Inc (NYSE:IRT) by 17.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 14,596,051 shares of the real estate investment trust’s stock after purchasing an additional 2,128,304 shares during the period. BlackRock Inc. owned about 0.17% of Independence Realty Trust worth $150,484,000 at the end of the most recent quarter.
- [By Stephan Byrd]
Shares of Independence Realty Trust Inc (NYSE:IRT) have been given an average recommendation of “Buy” by the nine research firms that are covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is $10.88.
Top 10 Low Price Stocks To Buy Right Now: LeMaitre Vascular, Inc.(LMAT)
Advisors' Opinion:- [By Brian Feroldi]
In response to reporting first-quarter results, shares of LeMaitre Vascular (NASDAQ:LMAT), a medical device maker focused on niche products used during vascular surgery, fell 20% as of 10:35 a.m. EDT on Thursday.
- [By Lisa Levin]
Shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT) were down 17 percent to $32.19 after the company reported weaker-than-expected Q1 results.
LKQ Corporation (NASDAQ: LKQ) was down, falling around 16 percent to $31.49 following weaker-than-expected quarterly earnings.
- [By Motley Fool Staff]
Competing against the industry giants can be brutal, so it can pay off to sidestep the competition by thinking small. That's the strategy that LeMaitre Vascular (NASDAQ:LMAT) has employed for decades to drive market-beating returns.
- [By Logan Wallace]
Get a free copy of the Zacks research report on LeMaitre Vascular (LMAT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Lisa Levin]
Shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT) were down 17 percent to $32.47 after the company reported weaker-than-expected Q1 results.
Essendant Inc (NASDAQ: ESND) was down, falling around 23 percent to $7.38 after reporting downbeat quarterly earnings.
Top 10 Low Price Stocks To Buy Right Now: Civista Bancshares, Inc. (CIVB)
Advisors' Opinion:- [By Max Byerly]
Shares of Civista Bancshares Inc (NASDAQ:CIVB) have earned an average recommendation of “Buy” from the eight ratings firms that are covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokerages that have covered the stock in the last year is $25.80.
- [By Max Byerly]
Get a free copy of the Zacks research report on Civista Bancshares (CIVB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Lakeland Financial (NASDAQ:LKFN) and Civista Bancshares (NASDAQ:CIVB) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability.
No comments:
Post a Comment